CONMED
CNMD · Health Care Equipment
$49.25
0.4%Glaukos
GKOS · Health Care Equipment
$178.88
1.2%The short version
- CONMED is the larger business, with $1.4B of revenue in fiscal 2025 against $507M for Glaukos, about 2.7 times as much.
- Glaukos grew revenue faster (32.3%, against 5.2%).
- CONMED kept more of each dollar of sales as operating profit (7.5% operating margin, against −39.3% operating margin).
- CONMED turned more of its sales into free cash flow (11.0% FCF margin, against −4.4% FCF margin).
| Latest fiscal year | CNMD · FY25 | GKOS · FY25 |
|---|---|---|
| Size | ||
| Market cap | $1.5B | $10.5B |
| Revenue | $1.4B | $507M |
| Free cash flow | $151M | −$22.5M |
| Net income | $47.1M | −$188M |
| Growth | ||
| Revenue growth | 5.2% | 32.3% |
| 5-year growth | 9.8% | 17.7% |
| Share count change | 0.0% | 8.4% |
| Profitability | ||
| Gross margin | 54.6% | 55.7% |
| Operating margin | 7.5% | −39.3% |
| Net margin | 3.4% | −37.0% |
| FCF margin | 11.0% | −4.4% |
| Return on capital | 3.7% | — |
| Return on equity | 4.7% | −26.4% |
| Balance sheet | ||
| Net debt | $794M | — |
| Net debt / EBITDA | 5.1x | — |
| Dividends and buybacks | $24.7M | $0.0M |
| Valuation & quality | ||
| P/E | 32.6x | — |
| Piotroski F-score | 6 | — |
FY16
CNMD $764M
GKOS $114M
FY17
CNMD $796M
GKOS $159M
FY18
CNMD $860M
GKOS $181M
FY19
CNMD $955M
GKOS $237M
FY20
CNMD $863M
GKOS $225M
FY21
CNMD $1.0B
GKOS $294M
FY22
CNMD $1.0B
GKOS $283M
FY23
CNMD $1.2B
GKOS $315M
FY24
CNMD $1.3B
GKOS $384M
FY25
CNMD $1.4B
GKOS $507M
CNMD
GKOS
FY16
CNMD 4.9%
GKOS 3.7%
FY17
CNMD 5.9%
GKOS −1.4%
FY18
CNMD 8.3%
GKOS −7.2%
FY19
CNMD 8.3%
GKOS −21.2%
FY20
CNMD 5.3%
GKOS −54.9%
FY21
CNMD 10.9%
GKOS −11.2%
FY22
CNMD 6.7%
GKOS −29.1%
FY23
CNMD 9.7%
GKOS −40.9%
FY24
CNMD 15.3%
GKOS −31.9%
FY25
CNMD 7.5%
GKOS −39.3%
CNMD
GKOS
FY16
CNMD $25.1M
GKOS $6.0M
FY17
CNMD $52.7M
GKOS $19.8M
FY18
CNMD $58.2M
GKOS $8.6M
FY19
CNMD $75.1M
GKOS −$5.1M
FY20
CNMD $51.5M
GKOS −$29.9M
FY21
CNMD $96.9M
GKOS −$23.1M
FY22
CNMD $11.6M
GKOS −$63.4M
FY23
CNMD $106M
GKOS −$78.0M
FY24
CNMD $154M
GKOS −$67.6M
FY25
CNMD $151M
GKOS −$22.5M
CNMD
GKOS
FY16
CNMD 3.1%
GKOS —
FY17
CNMD 4.4%
GKOS —
FY18
CNMD 5.3%
GKOS —
FY19
CNMD 5.7%
GKOS —
FY20
CNMD 3.2%
GKOS —
FY21
CNMD 6.5%
GKOS −5.1%
FY22
CNMD 3.4%
GKOS −10.2%
FY23
CNMD 5.4%
GKOS −13.7%
FY24
CNMD 9.0%
GKOS —
FY25
CNMD 3.7%
GKOS —
CNMD
GKOS
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.